Thermo Fisher Scientific (TMO) Change in Account Payables (2009 - 2020)

Thermo Fisher Scientific has disclosed Change in Account Payables across 12 years of filings, most recently posting $279.0 million for Q4 2020.

• Quarterly Change in Account Payables rose 42.35% year-over-year to $279.0 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $59.0 million (down 77.82% YoY) and the FY2025 annual result came in at $421.0 million, up 98.58% from the prior year.
• Change in Account Payables advanced to $279.0 million in Q4 2020, from $277.0 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $279.0 million in Q4 2020 and troughed at -$256.0 million in Q2 2020.
• A 5-year average of $42.8 million and a median of $15.6 million in 2016 frame the typical range for Change in Account Payables.
• Biggest YoY gain for Change in Account Payables was 2812.87% in 2017; the steepest drop was 1374.51% in 2017.
• Tracing TMO's Change in Account Payables over 5 years: stood at -$10.1 million in 2016, then surged by 2812.87% to $274.0 million in 2017, then decreased by 10.22% to $246.0 million in 2018, then declined by 20.33% to $196.0 million in 2019, then soared by 42.35% to $279.0 million in 2020.
• Business Quant data shows TMO's Change in Account Payables at $279.0 million in Q4 2020, $277.0 million in Q3 2020, and -$256.0 million in Q2 2020.